PFE logo

Pfizer Inc. (PFE) Cost of goods sold

annual cost of goods sold:

$21.78B-$7.43B(-25.44%)
December 31, 2024

Summary

  • As of today (August 20, 2025), PFE annual cost of goods sold is $21.78 billion, with the most recent change of -$7.43 billion (-25.44%) on December 31, 2024.
  • During the last 3 years, PFE annual cost of goods sold has fallen by -$12.63 billion (-36.71%).
  • PFE annual cost of goods sold is now -43.04% below its all-time high of $38.24 billion, reached on December 31, 2022.

Performance

PFE Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

quarterly cost of goods sold:

$5.23B+$1.34B(+34.59%)
June 29, 2025

Summary

  • As of today (August 20, 2025), PFE quarterly cost of goods sold is $5.23 billion, with the most recent change of +$1.34 billion (+34.59%) on June 29, 2025.
  • Over the past year, PFE quarterly cost of goods sold has increased by +$193.00 million (+3.83%).
  • PFE quarterly cost of goods sold is now -51.99% below its all-time high of $10.90 billion, reached on December 31, 2022.

Performance

PFE quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

TTM cost of goods sold:

$20.85B+$193.00M(+0.93%)
June 29, 2025

Summary

  • As of today (August 20, 2025), PFE TTM cost of goods sold is $20.85 billion, with the most recent change of +$193.00 million (+0.93%) on June 29, 2025.
  • Over the past year, PFE TTM cost of goods sold has dropped by -$7.77 billion (-27.14%).
  • PFE TTM cost of goods sold is now -49.64% below its all-time high of $41.40 billion, reached on June 1, 2022.

Performance

PFE TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

PFE Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.4%+3.8%-27.1%
3 y3 years-36.7%-42.3%-49.6%
5 y5 years+72.5%+95.1%+62.0%

PFE Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-43.0%at low-52.0%+34.6%-49.6%+0.9%
5 y5-year-43.0%+85.0%-52.0%+95.1%-49.6%+74.7%
alltimeall time-43.0%+1403.2%-52.0%+5779.8%-49.6%+4595.3%

PFE Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$5.23B(+34.6%)
$20.85B(+0.9%)
Mar 2025
-
$3.89B(-18.9%)
$20.65B(-2.3%)
Dec 2024
$21.78B(-25.4%)
$4.79B(-30.8%)
$21.15B(-15.2%)
Sep 2024
-
$6.93B(+37.5%)
$24.94B(-12.8%)
Jun 2024
-
$5.04B(+15.0%)
$28.61B(+1.6%)
Mar 2024
-
$4.38B(-49.0%)
$28.17B(-5.3%)
Dec 2023
$29.21B(-23.6%)
$8.59B(-19.0%)
$29.74B(-7.2%)
Sep 2023
-
$10.60B(+130.8%)
$32.05B(+12.7%)
Jun 2023
-
$4.59B(-22.8%)
$28.43B(-13.6%)
Mar 2023
-
$5.95B(-45.4%)
$32.91B(-12.8%)
Dec 2022
$38.24B(+11.1%)
$10.90B(+56.0%)
$37.75B(+0.6%)
Sep 2022
-
$6.99B(-22.9%)
$37.53B(-9.3%)
Jun 2022
-
$9.07B(-16.0%)
$41.40B(+3.0%)
Mar 2022
-
$10.80B(+1.1%)
$40.18B(+16.9%)
Dec 2021
$34.41B(+192.4%)
$10.68B(-1.6%)
$34.38B(+25.5%)
Sep 2021
-
$10.86B(+38.4%)
$27.39B(+41.3%)
Jun 2021
-
$7.84B(+57.0%)
$19.39B(+36.3%)
Mar 2021
-
$5.00B(+35.4%)
$14.23B(+18.5%)
Dec 2020
$11.77B(-6.7%)
$3.69B(+29.2%)
$12.01B(+0.6%)
Sep 2020
-
$2.86B(+6.5%)
$11.93B(-7.3%)
Jun 2020
-
$2.68B(-3.4%)
$12.87B(-7.6%)
Mar 2020
-
$2.78B(-23.2%)
$13.92B(-5.5%)
Dec 2019
$12.62B(-21.1%)
$3.62B(-4.7%)
$14.74B(-4.4%)
Sep 2019
-
$3.79B(+1.6%)
$15.42B(-0.8%)
Jun 2019
-
$3.74B(+4.0%)
$15.55B(-2.2%)
Mar 2019
-
$3.59B(-16.3%)
$15.90B(-0.8%)
Dec 2018
$16.01B(+1.5%)
$4.29B(+9.4%)
$16.03B(-0.6%)
Sep 2018
-
$3.93B(-3.9%)
$16.12B(-0.2%)
Jun 2018
-
$4.09B(+9.7%)
$16.16B(+1.6%)
Mar 2018
-
$3.73B(-15.0%)
$15.90B(+0.6%)
Dec 2017
$15.78B(-1.1%)
$4.38B(+10.8%)
$15.80B(+1.3%)
Sep 2017
-
$3.96B(+3.3%)
$15.60B(-0.0%)
Jun 2017
-
$3.83B(+5.7%)
$15.60B(-1.3%)
Mar 2017
-
$3.63B(-13.2%)
$15.81B(-0.9%)
Dec 2016
$15.95B(+21.3%)
$4.18B(+5.5%)
$15.96B(-0.8%)
Sep 2016
-
$3.96B(-2.1%)
$16.08B(+5.6%)
Jun 2016
-
$4.04B(+7.3%)
$15.23B(+7.4%)
Mar 2016
-
$3.77B(-12.4%)
$14.18B(+7.8%)
Dec 2015
$13.16B(-1.1%)
$4.30B(+38.3%)
$13.16B(+5.7%)
Sep 2015
-
$3.11B(+3.8%)
$12.45B(-1.2%)
Jun 2015
-
$3.00B(+9.0%)
$12.60B(-2.9%)
Mar 2015
-
$2.75B(-23.5%)
$12.97B(-2.5%)
Dec 2014
$13.31B(-4.6%)
$3.59B(+10.1%)
$13.31B(-1.9%)
Sep 2014
-
$3.26B(-3.1%)
$13.56B(-0.6%)
Jun 2014
-
$3.37B(+9.3%)
$13.64B(+0.4%)
Mar 2014
-
$3.08B(-19.9%)
$13.59B(-5.3%)
Dec 2013
$13.95B(-4.7%)
$3.85B(+15.0%)
$14.36B(-3.4%)
Sep 2013
-
$3.35B(+0.8%)
$14.86B(-2.9%)
Jun 2013
-
$3.32B(-13.7%)
$15.31B(-4.2%)
Mar 2013
-
$3.85B(-11.5%)
$15.97B(-2.8%)
Dec 2012
$14.64B(-14.7%)
$4.35B(+14.5%)
$16.44B(-3.4%)
Sep 2012
-
$3.80B(-4.7%)
$17.02B(-6.6%)
Jun 2012
-
$3.98B(-7.7%)
$18.23B(-5.4%)
Mar 2012
-
$4.32B(-12.5%)
$19.28B(-2.9%)
Dec 2011
$17.16B(-17.1%)
$4.93B(-1.6%)
$19.86B(-3.1%)
Sep 2011
-
$5.01B(-0.4%)
$20.49B(+1.0%)
Jun 2011
-
$5.03B(+2.7%)
$20.29B(-0.3%)
Mar 2011
-
$4.90B(-11.8%)
$20.35B(-3.8%)
Dec 2010
$20.71B(+78.7%)
$5.55B(+15.5%)
$21.16B(+2.6%)
Sep 2010
-
$4.81B(-5.5%)
$20.63B(+13.5%)
Jun 2010
-
$5.09B(-10.8%)
$18.18B(+18.2%)
Mar 2010
-
$5.70B(+13.5%)
$15.38B(+32.7%)
Dec 2009
$11.59B(+15.5%)
$5.03B(+113.0%)
$11.59B(+33.8%)
Sep 2009
-
$2.36B(+2.9%)
$8.66B(-2.4%)
Jun 2009
-
$2.29B(+20.1%)
$8.87B(-4.8%)
Mar 2009
-
$1.91B(-8.8%)
$9.32B(-7.1%)
Dec 2008
$10.04B(-14.4%)
$2.10B(-18.5%)
$10.04B(-9.1%)
Sep 2008
-
$2.57B(-6.2%)
$11.04B(-19.4%)
Jun 2008
-
$2.74B(+4.4%)
$13.68B(+0.1%)
Mar 2008
-
$2.63B(-15.1%)
$13.66B(+0.1%)
Dec 2007
$11.72B(+11.6%)
$3.10B(-40.7%)
$13.64B(+1.3%)
Sep 2007
-
$5.22B(+91.7%)
$13.47B(+22.9%)
Jun 2007
-
$2.72B(+4.4%)
$10.96B(+2.0%)
Mar 2007
-
$2.61B(-10.6%)
$10.74B(+1.1%)
Dec 2006
$10.51B
$2.92B(+7.7%)
$10.63B(-1.4%)
Sep 2006
-
$2.71B(+8.0%)
$10.79B(+2.3%)
DateAnnualQuarterlyTTM
Jun 2006
-
$2.51B(+0.5%)
$10.55B(-3.9%)
Mar 2006
-
$2.50B(-18.8%)
$10.98B(-4.5%)
Dec 2005
$10.51B(-3.6%)
$3.07B(+24.6%)
$11.50B(+7.1%)
Sep 2005
-
$2.47B(-16.1%)
$10.74B(-0.1%)
Jun 2005
-
$2.94B(-2.6%)
$10.76B(+3.6%)
Mar 2005
-
$3.02B(+30.3%)
$10.38B(+3.8%)
Dec 2004
$10.90B(+18.6%)
$2.32B(-6.7%)
$10.00B(-9.6%)
Sep 2004
-
$2.48B(-3.1%)
$11.05B(-11.1%)
Jun 2004
-
$2.56B(-2.8%)
$12.43B(+4.5%)
Mar 2004
-
$2.64B(-21.8%)
$11.90B(+15.2%)
Dec 2003
$9.20B(+127.3%)
$3.37B(-12.6%)
$10.33B(+41.8%)
Sep 2003
-
$3.86B(+90.5%)
$7.28B(+53.8%)
Jun 2003
-
$2.03B(+90.3%)
$4.73B(+21.3%)
Mar 2003
-
$1.06B(+224.7%)
$3.90B(-3.5%)
Dec 2002
$4.04B(-21.3%)
$328.00M(-75.0%)
$4.04B(-23.7%)
Sep 2002
-
$1.31B(+9.8%)
$5.30B(+2.7%)
Jun 2002
-
$1.20B(-0.7%)
$5.17B(+0.9%)
Mar 2002
-
$1.21B(-24.0%)
$5.12B(-0.4%)
Dec 2001
$5.14B(+0.2%)
$1.59B(+34.7%)
$5.14B(+0.3%)
Sep 2001
-
$1.18B(+2.3%)
$5.12B(-0.3%)
Jun 2001
-
$1.15B(-6.0%)
$5.14B(-0.1%)
Mar 2001
-
$1.22B(-22.1%)
$5.14B(+16.4%)
Dec 2000
$5.13B(+99.3%)
$1.57B(+31.6%)
$4.42B(+23.1%)
Sep 2000
-
$1.19B(+3.4%)
$3.59B(+12.0%)
Jun 2000
-
$1.16B(+131.0%)
$3.21B(+45.5%)
Mar 2000
-
$500.00M(-32.5%)
$2.20B(-2.5%)
Dec 1999
$2.57B(+22.8%)
$741.00M(-8.4%)
$2.26B(+2.1%)
Sep 1999
-
$809.00M(+428.8%)
$2.21B(+17.8%)
Jun 1999
-
$153.00M(-72.5%)
$1.88B(-18.7%)
Mar 1999
-
$557.00M(-19.9%)
$2.31B(+0.5%)
Dec 1998
$2.10B(-10.6%)
$695.00M(+46.6%)
$2.30B(+13.5%)
Sep 1998
-
$474.00M(-19.1%)
$2.03B(+9.7%)
Jun 1998
-
$586.00M(+7.5%)
$1.85B(+12.5%)
Mar 1998
-
$545.00M(+29.1%)
$1.64B(+7.5%)
Dec 1997
$2.34B(+4.4%)
$422.00M(+43.1%)
$1.53B(+27.9%)
Sep 1997
-
$295.00M(-22.4%)
$1.20B(-9.5%)
Jun 1997
-
$380.00M(-11.8%)
$1.32B(-2.6%)
Mar 1997
-
$431.00M(+384.3%)
$1.35B(+1.4%)
Dec 1996
$2.25B(+1.4%)
$89.00M(-78.8%)
$1.34B(-21.7%)
Sep 1996
-
$420.00M(+1.2%)
$1.71B(-3.2%)
Jun 1996
-
$415.00M(+0.7%)
$1.76B(-5.3%)
Mar 1996
-
$412.00M(-10.4%)
$1.86B(-1.3%)
Dec 1995
$2.21B(+15.4%)
$459.60M(-3.4%)
$1.88B(-0.4%)
Sep 1995
-
$475.60M(-7.3%)
$1.89B(+3.9%)
Jun 1995
-
$512.80M(+17.6%)
$1.82B(+7.0%)
Mar 1995
-
$435.90M(-6.8%)
$1.70B(+4.6%)
Dec 1994
$1.92B(+8.3%)
$467.90M(+15.6%)
$1.63B(+3.8%)
Sep 1994
-
$404.80M(+2.6%)
$1.57B(+2.1%)
Jun 1994
-
$394.40M(+9.2%)
$1.54B(+1.3%)
Mar 1994
-
$361.10M(-11.5%)
$1.52B(-0.0%)
Dec 1993
$1.77B(-12.5%)
$408.10M(+9.5%)
$1.52B(-3.2%)
Sep 1993
-
$372.70M(-0.3%)
$1.57B(-5.0%)
Jun 1993
-
$374.00M(+3.5%)
$1.65B(-3.3%)
Mar 1993
-
$361.30M(-21.0%)
$1.70B(-3.3%)
Dec 1992
$2.02B(-8.0%)
$457.60M(+0.5%)
$1.76B(-5.2%)
Sep 1992
-
$455.10M(+5.9%)
$1.86B(-1.5%)
Jun 1992
-
$429.90M(+2.3%)
$1.89B(-1.4%)
Mar 1992
-
$420.30M(-24.1%)
$1.91B(-2.2%)
Dec 1991
$2.20B(-2.6%)
$553.40M(+14.6%)
$1.96B(-2.2%)
Sep 1991
-
$482.70M(+5.7%)
$2.00B(-1.6%)
Jun 1991
-
$456.50M(-1.6%)
$2.03B(-1.0%)
Mar 1991
-
$463.90M(-22.4%)
$2.05B(+1.0%)
Dec 1990
$2.26B(+9.6%)
$597.90M(+15.9%)
$2.03B(+41.6%)
Sep 1990
-
$515.90M(+8.3%)
$1.44B(+56.1%)
Jun 1990
-
$476.20M(+7.3%)
$920.20M(+107.3%)
Mar 1990
-
$444.00M
$444.00M
Dec 1989
$2.06B(+2.1%)
-
-
Dec 1988
$2.02B(+6.5%)
-
-
Dec 1987
$1.90B(+10.3%)
-
-
Dec 1986
$1.72B(+11.3%)
-
-
Dec 1985
$1.55B(+1.4%)
-
-
Dec 1984
$1.52B(-1.3%)
-
-
Dec 1983
$1.54B(+0.7%)
-
-
Dec 1982
$1.53B(-1.2%)
-
-
Dec 1981
$1.55B(+7.0%)
-
-
Dec 1980
$1.45B
-
-

FAQ

  • What is Pfizer Inc. annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Pfizer Inc.?
  • What is Pfizer Inc. annual cost of goods sold year-on-year change?
  • What is Pfizer Inc. quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Pfizer Inc.?
  • What is Pfizer Inc. quarterly cost of goods sold year-on-year change?
  • What is Pfizer Inc. TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Pfizer Inc.?
  • What is Pfizer Inc. TTM cost of goods sold year-on-year change?

What is Pfizer Inc. annual cost of goods sold?

The current annual cost of goods sold of PFE is $21.78B

What is the all time high annual cost of goods sold for Pfizer Inc.?

Pfizer Inc. all-time high annual cost of goods sold is $38.24B

What is Pfizer Inc. annual cost of goods sold year-on-year change?

Over the past year, PFE annual cost of goods sold has changed by -$7.43B (-25.44%)

What is Pfizer Inc. quarterly cost of goods sold?

The current quarterly cost of goods sold of PFE is $5.23B

What is the all time high quarterly cost of goods sold for Pfizer Inc.?

Pfizer Inc. all-time high quarterly cost of goods sold is $10.90B

What is Pfizer Inc. quarterly cost of goods sold year-on-year change?

Over the past year, PFE quarterly cost of goods sold has changed by +$193.00M (+3.83%)

What is Pfizer Inc. TTM cost of goods sold?

The current TTM cost of goods sold of PFE is $20.85B

What is the all time high TTM cost of goods sold for Pfizer Inc.?

Pfizer Inc. all-time high TTM cost of goods sold is $41.40B

What is Pfizer Inc. TTM cost of goods sold year-on-year change?

Over the past year, PFE TTM cost of goods sold has changed by -$7.77B (-27.14%)
On this page